Skip to main content
Fig. 2 | Annals of Clinical Microbiology and Antimicrobials

Fig. 2

From: Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study

Fig. 2

Box-and-whisker plot of GC dose (median and interquartile range) at PJP diagnosis. GC glucocorticoid; PJP Pneumocystis jiroveci pneumonia; IQR interquartile range; P15 glucocorticoid at 15 mg daily prednisolone-equivalent dose; SSC systemic sclerosis; AAV ANCA-associated vasculitis; IMM immune-mediated myositis; SLE systemic lupus erythematosus; RA rheumatoid arthritis

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us